Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

(VIDEO) Scottie Scheffler Frustrated At Caddie in Opening Round at Memorial LIV Golf’s Match

Published

on

Tyler Shough

DUBLIN, Ohio — Scottie Scheffler, the world’s top-ranked golfer and a two-time defending champion at the Memorial Tournament, carded a 1-over 73 in the first round Thursday, leaving him six shots off the lead amid challenging conditions at Muirfield Village Golf Club.

The performance, marked by visible frustration on the course, comes as the broader professional golf landscape grapples with uncertainty. Reports indicate that LIV Golf, the Saudi-backed circuit that disrupted the sport for years, is facing potential collapse at the end of the 2026 season, raising questions about the future integration of its players and the PGA Tour’s ability to absorb them without major disruptions.

Scheffler’s round started promisingly but unraveled on the back nine, highlighting the fine margins at Jack Nicklaus’ demanding layout. The world No. 1, seeking a historic third consecutive victory at the event, finished the front nine at 2 under but bogeyed the 10th and 14th holes before encountering major trouble at the par-3 16th.

Advertisement

His tee shot on the 16th came up short and found the water, leading to a double bogey. Cameras captured Scheffler, typically known for his composure, expressing clear agitation toward longtime caddie Ted Scott.

“I don’t know what to do. I can’t hear a word you’re saying. I feel like that was a good shot, now I’m in the water,” Scheffler was heard saying. He added, “I absolutely flush a seven iron, and we get the wind wrong, and I’m in the water.”

“I don’t think you understand how frustrating that is,” he continued. “I don’t understand. I really don’t. I mean, it was 5 yards short of the green. Flush 7-iron…I’ve hit good shots and dropping from hazards because we got the wind wrong.”

After the round, Scheffler elaborated to reporters on the wind’s impact.

Advertisement

“That’s just another really good iron shot, and the wind switched from down off the right to pretty significantly in off the right,” he said. “If it’s down off the right, that ball’s probably where I hit my wedge shot to. So just don’t really know what I’m supposed to do there outside of trying to hit a good shot, and then it’s frustrating when it doesn’t work out, especially when it doesn’t work out in that direction.”

“I would rather get gusted in off the left, not in off the right there. All you can do is just try to hit good shots. It can be very frustrating sometimes when you feel like you’re hitting good shots and then you’re going to the drop zone.”

Despite the setback, Scheffler birdied the par-4 17th to limit the damage. He sits tied for 33rd, with several players sharing the lead at 5 under or better in tough, wind-affected conditions.

The 2026 season has been solid but not dominant for Scheffler by his recent standards. He opened with a victory at The American Express but has posted a series of strong but winless results since, including top fives and near misses at events like the WM Phoenix Open, AT&T Pebble Beach Pro-Am, Masters, RBC Heritage and others. He fell short in his PGA Championship title defense but remains the clear favorite at Muirfield Village, where his ball-striking and course knowledge have shone in past years.

Advertisement

Muirfield Village, a Jack Nicklaus design, rewards precision and rewards the best players separating from the field. Scheffler has thrived here, winning in 2024 and 2025, and posting strong finishes earlier in the decade. A three-peat would tie him with Nicklaus’ own record of three straight wins from 1999-2001 at the event he hosts.

Yet Thursday’s round served as a reminder of golf’s unpredictability, even for the game’s dominant figure. Scheffler’s frustration, while rare, underscored the mental toll of elite competition under variable winds and firm conditions.

As attention turns to Friday’s second round, all eyes remain on whether Scheffler can mount a charge, much like his weekend surges in previous Memorials. The field includes stars like Rory McIlroy, who is seeking his first win at the event, and others looking to capitalize on any continued inconsistency from the world No. 1.

LIV Golf Turmoil Adds Layer of Complexity for PGA Tour

Advertisement

While Scheffler’s round provided on-course drama, off-course developments continue to reshape professional golf. LIV Golf, launched in 2022 with massive Saudi Public Investment Fund backing, is reportedly preparing for potential U.S. bankruptcy proceedings if new investors cannot be secured by season’s end. The PIF has signaled it will withdraw funding after 2026, leaving the league’s future in doubt.

The circuit’s collapse would mark the end of a tumultuous chapter that divided the golf world. Dozens of top players defected for guaranteed high payouts and team formats, leading to lawsuits, fractured relationships and a proposed but ultimately unmaterialized full merger with the PGA Tour.

Now, as LIV winds down, its players face uncertain futures. Reports indicate multiple LIV members or their representatives have reached out to the PGA Tour about potential returns, though pathways are expected to be more restrictive than previous re-entries. The PGA Tour must navigate reintegration carefully to maintain competitive balance, sponsor interests and fan engagement without alienating loyal members who stayed.

Bryson DeChambeau, one of LIV’s prominent figures, expressed shock at the developments and hinted at expanding his YouTube presence as a potential next step. Other stars like Jon Rahm have explored options, including DP World Tour accommodations to protect eligibility for events like the Ryder Cup.

Advertisement

For the PGA Tour, the situation presents both opportunity and challenge. A flood of high-profile returns could boost star power and viewership, but it risks diluting prize funds, complicating schedules and reopening old wounds. Commissioner Jay Monahan and officials have emphasized a merit-based system moving forward, with no automatic exemptions likely for former defectors.

This backdrop makes events like the Memorial — a signature PGA Tour stop — even more significant as a showcase for the tour’s enduring strength. Scheffler’s pursuit of history, alongside established and rising talents, reaffirms the PGA Tour’s position as the premier circuit, even as external pressures mount.

Fans and analysts alike will watch closely not just for leaderboard movement this week, but for how the tour positions itself amid the shifting sands of professional golf. Scheffler, ever the steady force, may yet provide the on-course anchor needed during these transitional times.

With three rounds remaining, the two-time major winner from the previous seasons remains well-positioned to contend, wind and all. Golf, as always, demands adaptability — a lesson Scheffler embodied in his post-round reflections and one the entire sport may soon need to apply on a larger scale.

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Russian group claims West African Resources ransomware attack

Published

on

Russian group claims West African Resources ransomware attack

A Russian hacking group has claimed to have gained access and installed ransomware on Subiaco-based ASX-listed gold miner West African Resources’ systems.

Continue Reading

Business

Commodities: Oil Slumps As The U.S. And Iran Pause Strikes

Published

on

Commodities: Oil Slumps As The U.S. And Iran Pause Strikes

Commodities: Oil Slumps As The U.S. And Iran Pause Strikes

Continue Reading

Business

Escalade Is Ready To Play (Rating Upgrade)

Published

on

Escalade Is Ready To Play (Rating Upgrade)

Escalade Is Ready To Play (Rating Upgrade)

Continue Reading

Business

D-Wave Quantum: A Lagging Roadmap And Overvalued Stock (NYSE:QBTS)

Published

on

D-Wave Quantum: A Lagging Roadmap And Overvalued Stock (NYSE:QBTS)

This article was written by

With a professional background spanning multiple industries, from ecnomocis to logistics and construction to retail, I bring a diverse perspective to investing. My international education and career experiences have provided me with a global outlook and the ability to analyze market dynamics from different cultural and economic perspectives. I have been actively investing for over a decade, honing a strategy that focuses on cyclical industries while maintaining a diversified portfolio that includes bonds, commodities, and forex. My interest in cyclical sectors stems from their potential for significant returns during periods of economic recovery and growth. However, I also recognize the importance of balancing risk, which is why I incorporate fixed-income investments (long or short).

Analyst’s Disclosure: I/we have a beneficial long position in the shares of IONQ, INFQ either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Why is Contemporary Amperex Technology stock rallying today?

Published

on


Why is Contemporary Amperex Technology stock rallying today?

Continue Reading

Business

Sterlite Tech shares jump 5% after CLSA upgrades 2026 multibagger after strong Q1 results

Published

on

Sterlite Tech shares jump 5% after CLSA upgrades 2026 multibagger after strong Q1 results
Shares of Vedanta-backed Sterlite Technologies rallied as much as 5% to their day’s high of Rs 592 on the BSE on Monday after international brokerage CLSA upgraded the stock to Outperform and assigned a target price of Rs 950, implying an upside of 68% from current market levels.

It’s been an unforgettable year for Sterlite Tech shareholders as the stock has rocketed 466% in 2026 alone.

What is CLSA saying?

The brokerage said Sterlite Technologies’ order book surged 155% QoQ to Rs 18,600 crore, pointing to a strong growth outlook. Factoring in the company’s recent Rs 1,500 crore QIP fundraising and the significant Q1 FY27 beat, CLSA raised its forecasts by 7-125% for FY27-29CL. The brokerage now sees Sterlite Technologies delivering a 62% EBITDA CAGR.
Sterlite Tech secured a multi-year contract worth $1.11 billion, or more than Rs 10,000 crore, to supply optical connectivity products for next-generation AI data centres. The company also received multiple hyperscaler orders worth more than $100 million for Neuralis, its integrated data centre solutions portfolio. It also won a strategic order to supply long-haul, dark-fibre high-density micro-cables to a major connectivity infrastructure provider.

Also read: Forget selling! FIIs doubled down on this AI multibagger stock that’s up 200% YTD

Advertisement

The order wins come as data centres require higher fibre density, faster data transmission and more efficient connectivity systems to handle AI workloads. STL has been positioning itself as a supplier of optical fibre, cables and integrated connectivity products for this buildout.


Sterlite Tech said it achieved a net debt-free balance sheet during the quarter after raising Rs 1,500 crore through a qualified institutional placement.
The company said the fundraise has strengthened its balance sheet and will help support the next phase of growth. Following the improvement in its financial position, CRISIL revised its rating outlook to “Stable”, while ICRA upgraded the company’s credit rating to “AA (Stable)”.The balance-sheet improvement is important for STL as it enters a larger order execution cycle. A stronger capital base gives the company more room to scale production, invest in products and manage working capital as orders rise.

Sterlite Tech Q1 results

Sterlite Technologies reported its strongest quarterly performance in Q1FY27, helped by higher demand for optical connectivity products, growth in its data centre business and a record order book linked to AI-ready digital infrastructure.

The company reported revenue of Rs 1,910 crore for the quarter ended June 30, up 87% from Rs 1,019 crore in the same quarter last year. Sequentially, revenue rose 33% from Rs 1,441 crore in Q4FY26. Profit after tax rose 870% to Rs 197 crore from Rs 10 crore a year earlier. In the March quarter, the company had reported PAT of Rs 59 crore.

Read more:
AI, data centre boom powers these 9 stocks up to 477% in 2026. Can you still join the party?

EBITDA rose to Rs 397 crore, compared with Rs 140 crore in Q1 and Rs 218 crore in the previous quarter. EBITDA margin stood at 20.8%, the highest in nearly 20 quarters, helped by a better product mix, operating leverage and higher contribution from the data centre business.

Advertisement

STL Managing Director Ankit Agarwal said Q1 FY27 was the strongest quarter in the company’s history, with record revenue and profitability reflecting the strength of its AI-ready digital infrastructure portfolio and the trust placed by hyperscalers and telecom operators.
He said the rapid scale-up of the Data Center business shows how decisively STL has aligned itself with the AI infrastructure buildout. With a record order book and strong customer trust, the company expects to continue delivering innovative and reliable solutions to support its customers’ growth.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

Continue Reading

Business

Dr Lal PathLabs shares soar 8% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages are saying?

Published

on

Dr Lal PathLabs shares soar 8% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages are saying?
Shares of Dr Lal PathLabs jumped nearly 8% on Monday to hit a new 52-week high after the diagnostics firm reported better-than-expected earnings for the first quarter of FY27, with multiple brokerages raising target prices.

Dr Lal PathLabs shares jumped to a fresh 52-week high of Rs 1,895 apiece on Monday, rising more than 12% in just two sessions. The stock is on track to record its sharpest single-day surge since early May this year.

The company on Friday reported a 28% year-on-year (YoY) increase in consolidated net profit to Rs 169.5 crore for the April-June quarter of FY27, from Rs 132.4 crore in the corresponding quarter of the previous financial year. The firm’s revenue from operations, meanwhile, rose over 19% YoY to Rs 797.7 crore during the quarter under review.

Along with the Q1 results, Dr Lal PathLabs announced an interim dividend of Rs 5 per equity share for the ongoing financial year 2027, with July 30 fixed as the record date to determine the eligibility of shareholders to receive the payout.

Advertisement


Also read |
Dr Lal PathLabs posts higher first-quarter profit on healthy demand for tests

Nomura on Dr Lal PathLabs share price

Nomura maintained its ‘Buy’ call on the shares of Dr Lal PathLabs but increased its target price to Rs 2,085 apiece from Rs 1,860 apiece. The latest target price implies an upside potential of 18.5% from the stock’s previous closing price of Rs 1,759.20 apiece.


The international brokerage said that the company’s Q1 earnings came ahead of its estimates. The beat was driven primarily by higher-than-expected realisations, aided by price hikes in the CGHS and ECHS schemes, it said, noting that management indicated that the benefit from the CGHS and ECHS price hikes should continue over the next 2–3 quarters.
For FY27, the company’s management has raised its revenue guidance to mid-teens from early-teens, implying an acceleration in growth on the back of stronger realisation. On margins, management has adopted a more conservative stance, maintaining EBITDA margin guidance at 27–28% as it intends to reinvest in capacity building while prioritising growth, Nomura said. “We, however, model FY27 revenue growth of 16.6% and an EBITDA margin of 28.9%. Beyond network expansion, a target of 12–15 lab additions in FY27, the company is investing in high-end tests, radiology and international market opportunities, with inorganic growth also on the table,” it further said.Nomura revised its FY27 estimates to reflect the strong Q1 results, factoring in higher revenue growth and lower EBITDA margins. Consequently, it raised its FY27F–29 earnings estimates by nearly 6%. “We believe Dr Lal PathLabs’ valuation is underpinned by strong volume growth and a robust balance sheet that supports its acquisition ambitions. We expect Dr Lal PathLabs to trade at least at the upper end of its pre-COVID range of 40–45x one-year-forward EPS. A higher market valuation, versus pre-COVID, stronger earnings growth, 18% EPS CAGR over FY26–29F versus 14% over FY16–19, and a higher dividend payout justify this valuation, in our view,” the international brokerage said.

Nuvama on Dr Lal PathLabs share price

Nuvama also noted that Dr Lal PathLabs beat earnings estimates. It said the company remains on a robust growth path owing to network expansion, 12–15 labs and 2–4 radiology centres in FY27, CGHS and ECHS price hike-led growth, sustained traction in the Delhi NCR market, double-digit growth, and a strong Suburban turnaround, along with a robust balance sheet which could unlock inorganic optionality.

The brokerage raised its earnings estimates for FY27 and FY28. It maintained its ‘Buy’ rating on the stock while increasing its target price to Rs 2,140 apiece. This implies an upside potential of nearly 22%.

Advertisement

JM Financial on Dr Lal PathLabs share price

JM Financial said Dr Lal delivered a strong Q1FY27, beating estimates by a substantial margin and delivering a second consecutive quarter of 15%+ growth. “We remain positive on Dr Lal, supported by its market leadership, structurally superior B2C mix, healthy cash generation and revival of structural growth in the industry,” it said.

The domestic brokerage maintained its ‘Buy’ call on Dr Lal PathLabs shares but increased its target price to Rs 2,195 apiece, implying nearly 25% upside.

Also read |
Why is market rising today? Sensex soars 600 points, Nifty above 23,900. 6 key factors driving the rally

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Advertisement
Continue Reading

Business

Delay for $22m project on Tsunami restaurant site in Mosman Park

Published

on

Delay for $22m project on Tsunami restaurant site in Mosman Park

The construction deadline for a $22 million project on the Tsunami restaurant site in Mosman Park has been pushed out 24 months, extending it to six years after the approval.

Continue Reading

Business

Ares Capital's Fat Yield Makes It Worth Keeping

Published

on

Ares Capital's Fat Yield Makes It Worth Keeping

Ares Capital's Fat Yield Makes It Worth Keeping

Continue Reading

Business

Esquire Financial: Earnings Accelerate Ahead Of Deal Completion

Published

on

Esquire Financial: Earnings Accelerate Ahead Of Deal Completion

Esquire Financial: Earnings Accelerate Ahead Of Deal Completion

Continue Reading

Trending

Copyright © 2025